Novo Nordisk has a price fix solution for uninsured patients with diabetes, but not for HSA holders or people with normal ...
Novo Nordisk's top executive faced a Senate grilling on Tuesday over the high prices of the company's weight loss drug Wegovy and diabetes treatment Ozempic, as demand for both injections soars in the ...
U.S. Sen. Bernie Sanders said major PBMs have agreed not to limit coverage of Ozempic and Wegovy if Novo lowers its prices.